Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,722 | -47,510 | -33,575 | -84,054 | -38,816 |
| Depreciation Amortization | 990 | 1,162 | 991 | 1,840 | 2,043 |
| Income taxes - deferred | N/A | N/A | N/A | -1,698 | -1,443 |
| Accounts receivable | 202 | -2,319 | -27 | 281 | -102 |
| Accounts payable and accrued liabilities | -6,540 | 62 | 6,182 | -117 | -1,143 |
| Other Working Capital | -6,110 | -7,626 | -547 | -156 | -2,702 |
| Other Operating Activity | 14,919 | 18,046 | 15,653 | 45,409 | 9,975 |
| Operating Cash Flow | $-11,261 | $-38,185 | $-11,323 | $-38,495 | $-32,188 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | -72 | -2,245 | -471 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -12,075 |
| Purchase Of Investment | -4,218 | -3,731 | -229,836 | -2,050,594 | -371,449 |
| Sale Of Investment | 3,725 | 3,980 | 288,287 | 2,086,852 | 286,670 |
| Purchase Sale Intangibles | N/A | -6,000 | -1,000 | N/A | -2,157 |
| Other Investing Activity | 0 | -6,000 | -1,094 | 0 | -2,800 |
| Investing Cash Flow | $-493 | $-5,752 | $57,285 | $34,013 | $-100,125 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 24,779 | N/A |
| Debt Repayment | -36,500 | -3,500 | N/A | N/A | -18,067 |
| Common Stock Issued | 24,409 | 27,710 | 14,725 | 312 | 137,445 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,081 |
| Other Financing Activity | -1,582 | -739 | -93 | -3,196 | -17,319 |
| Financing Cash Flow | $-13,673 | $23,471 | $14,632 | $21,895 | $100,978 |
| Exchange Rate Effect | -9 | 27 | -42 | -131 | 74 |
| Beginning Cash Position | 67,218 | 87,657 | 27,105 | 9,823 | 41,084 |
| End Cash Position | 41,782 | 67,218 | 87,657 | 27,105 | 9,823 |
| Net Cash Flow | $-25,436 | $-20,439 | $60,552 | $17,282 | $-31,261 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,261 | -38,185 | -11,323 | -38,495 | -32,188 |
| Capital Expenditure | N/A | -1 | -72 | -2,245 | -471 |
| Free Cash Flow | -11,261 | -38,186 | -11,395 | -40,740 | -32,659 |